Sesen Bio Inc.

NASDAQ:SESN  
2.33
+0.05 (+2.19%)
Products

Sesen Bio Submits Completed Biologics License Application To The FDA For Vicineum™ And Has Requested Priority Review

Published: 12/21/2020 16:31 GMT
Sesen Bio Inc. (SESN) - Sesen Bio Submits Completed Biologics License Application to the FDA for Vicineum™ and Has Requested Priority Review.